Arkolith/Insider Trading/NYMX/Form 4

Robinson James George

DirectorNYMOX PHARMACEUTICAL CORP (NYMX) · full profile →Form 4 · filed May 6, 2022
Net Buying
Open-Market Buys
$1.9M
Open-Market Sells
$0
Net Open-Market Flow
$1.9M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2022Buy(P)1.2M$1.65$1.9M4.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 2, 2022Buy(P)1.2M—$01.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640334-22-000918) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML